HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.805
+0.015 (0.84%)
Nov 21, 2024, 1:50 PM EST - Market open

HilleVax Statistics

Total Valuation

HilleVax has a market cap or net worth of $87.06 million. The enterprise value is -$78.00 million.

Market Cap 87.06M
Enterprise Value -78.00M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

HilleVax has 48.23 million shares outstanding. The number of shares has increased by 27.71% in one year.

Current Share Class 48.23M
Shares Outstanding 48.23M
Shares Change (YoY) +27.71%
Shares Change (QoQ) +0.41%
Owned by Insiders (%) 5.27%
Owned by Institutions (%) 55.50%
Float 28.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.47
P/TBV Ratio 0.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.25, with a Debt / Equity ratio of 0.14.

Current Ratio 14.25
Quick Ratio 13.68
Debt / Equity 0.14
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.60

Financial Efficiency

Return on equity (ROE) is -62.24% and return on invested capital (ROIC) is -30.39%.

Return on Equity (ROE) -62.24%
Return on Assets (ROA) -28.90%
Return on Capital (ROIC) -30.39%
Revenue Per Employee n/a
Profits Per Employee -$1.67M
Employee Count 90
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.82% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.

Beta (5Y) 0.77
52-Week Price Change -86.82%
50-Day Moving Average 1.83
200-Day Moving Average 8.50
Relative Strength Index (RSI) 41.12
Average Volume (20 Days) 133,289

Short Selling Information

The latest short interest is 1.18 million, so 2.44% of the outstanding shares have been sold short.

Short Interest 1.18M
Short Previous Month 1.26M
Short % of Shares Out 2.44%
Short % of Float 4.16%
Short Ratio (days to cover) 8.81

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -135.87M
Pretax Income -156.27M
Net Income -150.28M
EBITDA -134.04M
EBIT -135.87M
Earnings Per Share (EPS) -$3.09
Full Income Statement

Balance Sheet

The company has $189.31 million in cash and $24.97 million in debt, giving a net cash position of $164.34 million or $3.41 per share.

Cash & Cash Equivalents 189.31M
Total Debt 24.97M
Net Cash 164.34M
Net Cash Per Share $3.41
Equity (Book Value) 184.27M
Book Value Per Share 3.82
Working Capital 183.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.21 million and capital expenditures -$1.15 million, giving a free cash flow of -$113.36 million.

Operating Cash Flow -112.21M
Capital Expenditures -1.15M
Free Cash Flow -113.36M
FCF Per Share -$2.35
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.71%
Shareholder Yield -27.71%
Earnings Yield -174.06%
FCF Yield -131.29%

Analyst Forecast

The average price target for HilleVax is $2.33, which is 29.09% higher than the current price. The consensus rating is "Hold".

Price Target $2.33
Price Target Difference 29.09%
Analyst Consensus Hold
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -21.58%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1